SG Americas Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.23M Sell
91,078
-12,384
-12% -$1.14M 0.01% 858
2025
Q4
$9.3M Buy
103,462
+42,352
+69% +$4.02M 0.01% 807
2025
Q3
$6.02M Buy
61,110
+13,812
+29% +$1.37M 0.02% 445
2025
Q2
$4.31M Sell
47,298
-88,526
-65% -$8.56M 0.02% 506
2025
Q1
$15.4M Buy
135,824
+60,712
+81% +$6.49M 0.05% 239
2024
Q4
$7.93M Sell
75,112
-109,084
-59% -$11.7M 0.03% 260
2024
Q3
$19.9M Buy
184,196
+96,593
+110% +$10.5M 0.07% 164
2024
Q2
$9.51M Buy
87,603
+60,624
+225% +$7.15M 0.06% 345
2024
Q1
$3.56M Buy
26,979
+18,620
+223% +$2.33M 0.02% 667
2023
Q4
$1.02M Buy
8,359
+4,775
+133% +$533K 0.01% 1014
2023
Q3
$402K Sell
3,584
-9,657
-73% -$1.23M ﹤0.01% 1911
2023
Q2
$1.93M Buy
+13,241
New +$1.8M 0.01% 758
2022
Q4
Sell
-58,702
Closed -$6.14M 3431
2022
Q3
$6.14M Buy
58,702
+42,735
+268% +$4.69M 0.08% 230
2022
Q2
$1.68M Sell
15,967
-48,235
-75% -$5.72M 0.02% 850
2022
Q1
$8.21M Buy
64,202
+19,965
+45% +$2.41M 0.06% 259
2021
Q4
$5.46M Sell
44,237
-14,584
-25% -$1.91M 0.03% 450
2021
Q3
$8.36M Sell
58,821
-47,207
-45% -$6.94M 0.04% 325
2021
Q2
$16.6M Sell
106,028
-343,880
-76% -$55.7M 0.08% 216
2021
Q1
$69.9M Buy
449,908
+435,370
+2,995% +$67.4M 0.37% 39
2020
Q4
$2.17M Buy
14,538
+9,201
+172% +$1.3M 0.01% 1046
2020
Q3
$705K Sell
5,337
-20,942
-80% -$2.74M ﹤0.01% 1412
2020
Q2
$3.04M Buy
26,279
+1,902
+8% +$219K 0.03% 575
2020
Q1
$2.39M Buy
24,377
+23,313
+2,191% +$3.06M 0.02% 706
2019
Q4
$155K Sell
1,064
-68,197
-98% -$9.41M ﹤0.01% 2669
2019
Q3
$9.23M Sell
69,261
-15,256
-18% -$1.97M 0.08% 270
2019
Q2
$9.66M Buy
84,517
+6,120
+8% +$717K 0.07% 285
2019
Q1
$9.72M Buy
78,397
+23,877
+44% +$2.71M 0.09% 229
2018
Q4
$5.49M Sell
54,520
-6,494
-11% -$730K 0.05% 354
2018
Q3
$7.79M Buy
61,014
+16,961
+39% +$2.02M 0.06% 340
2018
Q2
$4.77M Sell
44,053
-11,641
-21% -$1.27M 0.04% 453
2018
Q1
$5.9M Buy
55,694
+23,221
+72% +$2.7M 0.05% 353
2017
Q4
$3.8M Buy
32,473
+31,250
+2,555% +$3.53M 0.04% 509
2017
Q3
$139K Sell
1,223
-30,104
-96% -$3.48M ﹤0.01% 2922
2017
Q2
$3.9M Sell
31,327
-1,687
-5% -$200K 0.04% 502
2017
Q1
$3.91M Sell
33,014
-9,299
-22% -$1.05M 0.03% 502
2016
Q4
$4.24M Buy
42,313
+30,166
+248% +$3.23M 0.04% 533
2016
Q3
$1.53M Buy
12,147
+1,242
+11% +$153K 0.02% 890
2016
Q2
$1.27M Sell
10,905
-3,478
-24% -$394K 0.01% 1143
2016
Q1
$1.49M Buy
14,383
+4,162
+41% +$403K 0.01% 1058
2015
Q4
$1.02M Sell
10,221
-5,352
-34% -$524K 0.01% 1132
2015
Q3
$1.42M Sell
15,573
-69,121
-82% -$6.93M 0.01% 738
2015
Q2
$8.98M Buy
84,694
+63,838
+306% +$7.06M 0.06% 226
2015
Q1
$2.38M Sell
20,856
-52,821
-72% -$6.03M 0.01% 740
2014
Q4
$8.11M Sell
73,677
-1,086
-1% -$114K 0.04% 446
2014
Q3
$7.3M Sell
74,763
-470,512
-86% -$46.3M 0.04% 396
2014
Q2
$55M Buy
545,275
+470,258
+627% +$45.9M 0.32% 62
2014
Q1
$6.89M Buy
75,017
+27,187
+57% +$2.51M 0.03% 543
2013
Q4
$4.33M Sell
47,830
-5,605
-10% -$485K 0.02% 706
2013
Q3
$4.26M Sell
53,435
-82,819
-61% -$6.52M 0.02% 660
2013
Q2
$9.91M Buy
+136,254
New +$10.2M 0.05% 374

Other funds holding ZBH

SG Americas Securities's ZBH Position: Q1 2026 in Review

SG Americas Securities reduced its Zimmer Biomet (ZBH) stake by 12% in Q1 2026, selling an estimated $1.14M and leaving 91,078 shares worth $8.23M. The position accounts for 0.01% of the portfolio, ranked #858.

SG Americas Securities first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $69.9M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • SG Americas Securities held 91,078 shares of Zimmer Biomet worth $8.23M as of Q1 2026.
  • SG Americas Securities sold 12,384 Zimmer Biomet shares in Q1 2026, an estimated $1.14M.
  • Zimmer Biomet made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #858 holding.
  • SG Americas Securities first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Zimmer Biomet position peaked at $69.9M in Q1 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.